News – Page 739 – Endpoints News

In the latest big investment in gene therapy manufacturing, Biogen commits $200M to a major new facility in NC

5 years ago

With $117M in fresh cash, Amunix paves path to the clinic for 'universal mask' prodrug on the hunt for HER2 tumors

5 years ago

Covid-19 roundup: EMA starts rolling review of Russia's Sputnik V; Novavax says shot is 51% effective against variant ...

5 years ago

BlackRock pushes Exscientia Series C to $100M as AI biotech boom continues

5 years ago

Latest MassBio report shows just how much biopharma's biggest sector boomed in 2020

5 years ago

David Liu has a new big idea: proteome editing. It could one day shred tau, RAS and some of the worst disease-causing ...

5 years ago

Eli Lilly claims a TKO in its long-running title fight with Novo Nordisk for the blockbuster diabetes market — but ...

5 years ago

Amid back office consolidation, Gilead axes 179 jobs in California

5 years ago

Peter Thiel-backed psychedelics player ATAI pulls in another nine-figure raise. But they're not ready to talk IPO — ...

5 years ago

Sofinnova Partners stays focused on late-stage deals with a new, $540M crossover fund

5 years ago

GSK, Vir's hopes for a Covid-19 antibody fall flat in NIH 'master protocol' with no benefit in hospitalized patients

5 years ago

Presage teams with Merck on its Phase 0 testing; KemPharm ADHD drug wins approval in children aged 6 and up

5 years ago

As BrainStorm continues to tout ‘clear signal’ on ALS drug, the FDA offers a rare public slapdown on the data

5 years ago

United axes PAH program Trevyent, once bought for cheap in acquisition of a rival, after FDA feedback

5 years ago

Swiss CDMO Celonic finds a home at Novartis' Stein hub, plans to add 250 new jobs centered on next-gen drugs

5 years ago

The 2021 top 100 biopharma investors: As the pandemic hit and IPOs boomed, VCs swung into action like never before

5 years ago

Eli Lilly claims success in a new JAK indication: hair loss

5 years ago

Fresh off $1B+ Merck deal, Janux locks down first private fundraise for its T cell engagers

5 years ago

A Jennifer Doudna-launched upstart nabs $115M for off-the-shelf CAR-Ts

5 years ago

Thank you, next: Takeda hands Ovid $196M cash to rein back in Phase III-ready seizure drug, reviving battered stock

5 years ago

Covid-19 roundup: Merck prepares new study on their $425M Covid drug; COVAX begins rollout but huge disparities still ...

5 years ago

As allogeneic cell therapy approaches flourish, Century loads up $160M to scale iPSC platform for CAR-T, CAR-NK

5 years ago

Khosla joins bet on unconventional startup looking to send drug delivering robots into the brain

5 years ago

One of Arena's top drugs flops in a PhIIb study for IBS pain. But researchers tease out a possible path forward as ...

5 years ago

First page Previous page 736 737 738739740 741 742 Next page Last page